Virios Therapeutics Inc (VIRI)

[McMagyar]

So wasn’t sure about the timing of $.50 raise..I didn’t look at date..
They were obviously looking at some responders thinking phase 3 and higher valuation was slam dunk..

Sadly although they were correct about success..they missed the lack of efficacy for those already being treated.


Do we go back to the $8 valuation with new fda support? With new drug perhaps rocking out phase 1 for long term covid?

Do they roll the bones again and wait for higher valuations?

BioPharm should always have two years of operational expaens in the bank..